PRICING OPTIMIZED FOR BUY AND BILL DRUGS!

"As an expert in drug billing, I find Buyandbill.com to be indispensable on a daily basis. It simply makes my life easier."
— Bobbi Buell, Principal, OnPoint Oncology

Discover the Power of BuyandBill.com Pro!

BuyandBill.com Pro offers:

  1. Optimized Pricing for ‘Buy and Bill’
  2. Package and NDC Level Pricing
  3. Precise NDC-HCPCS Alignments
  4. Historical Pricing and Analytics
  5. True ASP
  6. Quarterly Pricing Reports
  7. Vaccine Price Reporting
  8. Oral Drug Pricing
  9. Medicare Claims Data
  10. Drug Pipeline Report
"As an expert in drug billing, I find Buyandbill.com to be indispensable on a daily basis. It simply makes my life easier."
— Bobbi Buell, Principal, OnPoint Oncology
“As a consultant that develops in-depth GTN and ASP forecasting models for pharmaceutical companies, BuyandBill.com Pro is my go-to source for all related data points for medical and pharmacy benefit drug pricing data. The Pro version provides not only the data points, but more importantly, 8 years of historical pricing in both tabular and graphical trend formats. “
— President, Weiser Consulting
“I use buyandbill.com probably daily in my work as it is a great resource for quickly finding any drug ASP amount and Medicare reimbursement amount, as these change quarterly. We are analyzing constantly how these changes affect our reimbursement and model in our costs too. We also use this tool to see the AWP and WAC for oral drugs. Buy and Bill is the only resource I know of with the wealth of information that is valuable to help the practices we work with manage finances on a daily basis.”
— Business Operations Coordinator, Prologics Healthcare
"I refer to Buyandbill.com daily. No other drug pricing resource is as concise and informative as Buyandbill.com. BNB.com provides 9 years of historic pricing data calculated at the HCPCS level which allows me to analyze the competitive landscape and develop informed pricing and contracting decisions for our Medical Benefit drugs.”
— VP Market Access, Mid-Sized Biotech Company
Previous slide
Next slide